These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 25370350)

  • 1. Levels of N-terminal pro brain natriuretic peptide are enhanced in people with the uncomplicated metabolic syndrome: a case-cohort analysis of the population-based Casale Monferrato study.
    Bruno G; Barutta F; Landi A; Pinach S; Caropreso P; Mengozzi G; Baldassarre S; Fragapani S; Civera S; Cavallo Perin P; Gruden G
    Diabetes Metab Res Rev; 2015 May; 31(4):360-7. PubMed ID: 25370350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NTproBNP in insulin-resistance mediated conditions: overweight/obesity, metabolic syndrome and diabetes. The population-based Casale Monferrato Study.
    Baldassarre S; Fragapani S; Panero A; Fedele D; Pinach S; Lucchiari M; Vitale AR; Mengozzi G; Gruden G; Bruno G
    Cardiovasc Diabetol; 2017 Sep; 16(1):119. PubMed ID: 28946871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-terminal pro brain natriuretic peptide is inversely related to metabolic cardiovascular risk factors and the metabolic syndrome.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Borch-Johnsen K; Ibsen H; Jørgensen T; Hildebrandt P
    Hypertension; 2005 Oct; 46(4):660-6. PubMed ID: 16129819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal pro-B-type natriuretic peptide is inversely associated with metabolic syndrome in hypertensive patients.
    Chang HR; Hsieh JC; Hsu BG; Wang LY; Yu-Chih Chen M; Wang JH
    Am J Med Sci; 2014 Sep; 348(3):210-4. PubMed ID: 24736765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NT-proBNP linking low-moderately impaired renal function and cardiovascular mortality in diabetic patients: the population-based Casale Monferrato Study.
    Bruno G; Barutta F; Landi A; Cavallo Perin P; Gruden G
    PLoS One; 2014; 9(12):e114855. PubMed ID: 25503636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index.
    Sezen Y; Baş M; Demirbag R; Yildiz A; Celik H; Aksoy S
    Clin Biochem; 2009 Oct; 42(15):1500-3. PubMed ID: 19615987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of metabolic syndrome and diabetes mellitus on the N-terminal pro-B-type natriuretic peptide level and its prognostic performance in patients with coronary artery disease.
    Huang FY; Peng Y; Deng XX; Huang BT; Xia TL; Gui YY; Liu RS; Yang Y; Pu XB; Chen SJ; Chen F; Zhu Y; Chen M
    Coron Artery Dis; 2017 Mar; 28(2):159-165. PubMed ID: 28045698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and the metabolic syndrome are associated with arterial stiffness in patients with chronic kidney disease.
    Chan DT; Watts GF; Irish AB; Ooi EM; Dogra GK
    Am J Hypertens; 2013 Sep; 26(9):1155-61. PubMed ID: 23736110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse Association of N-terminal Pro‒B-type Natriuretic Peptide Level With Metabolic Syndrome in Kidney Transplant Patients.
    Lee KM; Lee MC; Lee CJ; Chen YC; Hsu BG
    Transplant Proc; 2018 Oct; 50(8):2496-2501. PubMed ID: 30316385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship between serum N-terminal pro-brain natriuretic peptide and metabolic syndrome: a cross-sectional study].
    Feng SQ; Ye P; Luo LM; Xiao WK; Xu RY; Wu HM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Feb; 41(2):130-4. PubMed ID: 23710744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of amino-terminal pro-brain natriuretic peptide with metabolic syndrome.
    Li WY; Chiu FC; Chien YF; Lin JW; Hwang JJ
    Intern Med; 2011; 50(11):1143-7. PubMed ID: 21628927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the metabolic syndrome on the predictive values of new risk markers in the general population.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hum Hypertens; 2008 Sep; 22(9):634-40. PubMed ID: 18528412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the clinical usefulness of the metabolic syndrome? The Casale Monferrato study.
    Bruno G; Fornengo P; Segre O; Novelli G; Panero F; Perotto M; Zucco C; Bargero G; Cavallo-Perin P
    J Hypertens; 2009 Dec; 27(12):2403-8. PubMed ID: 19738492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimated glomerular filtration rate is associated with both arterial stiffness and N-terminal pro-brain natriuretic peptide in newly diagnosed hypertensive patients.
    Gür M; Uçar H; Kuloğlu O; Kıvrak A; Şeker T; Türkoğlu C; Özaltun B; Kaypaklı O; Şahin DY; Elbasan Z; Tanboğa Hİ; Çaylı M
    Clin Exp Hypertens; 2014; 36(6):374-9. PubMed ID: 24432984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction.
    Goussot S; Mousson C; Guenancia C; Stamboul K; Brunel P; Brunet D; Touzery C; Cottin Y; Zeller M
    Am J Cardiol; 2015 Sep; 116(6):865-71. PubMed ID: 26183794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between glomerular filtration rate and plasma N-terminal pro B-type natriuretic peptide concentrations in dogs with chronic kidney disease.
    Miyagawa Y; Tominaga Y; Toda N; Takemura N
    Vet J; 2013 Aug; 197(2):445-50. PubMed ID: 23570775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma level of N-terminal pro brain natriuretic peptide (NT-proBNP) in elderly population in Poland--the PolSenior Study.
    Nadrowski P; Chudek J; Grodzicki T; Mossakowska M; Skrzypek M; Wiecek A; Zdrojewski T; Kozakiewicz K
    Exp Gerontol; 2013 Sep; 48(9):852-7. PubMed ID: 23770107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
    Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
    Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between N-terminal pro-B-type natriuretic peptide plasma levels and renal function evaluated with different formulae in older adult subjects admitted because of dyspnea.
    Fabbian F; De Giorgi A; Portaluppi F; Zuliani G
    Gerontology; 2012; 58(1):50-5. PubMed ID: 21540563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.